Salvage strategies for nonresponders to phosphodiesterase-5 inhibitor treatment for erectile dysfunction in the aging male

Author： Brant William O Brock Gerald B Lue Tom F Gerridzen Ronald G Bella Anthony J

Publisher： Future Medicine

ISSN： 1745-509X

Source： Aging Health, Vol.3, Iss.4, 2007-08, pp. : 527-542

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Avanafil: a new phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction

By Hatzimouratidis Konstantinos

Aging Health, Vol. 6, Iss. 5, 2010-10 ,pp. : 599-605

Future Medicine

Access to resources Recommend Favorite

Salvage therapy trial for erectile dysfunction using phosphodiesterase type 5 inhibitors and vitamin E: Preliminary report

By Kondoh Nobuyuki Higuchi Yoshihide Maruyama Takuo Nojima Michio Yamamoto Shingo Shima Hiroki

The Aging Male, Vol. 11, Iss. 4, 2008-07 ,pp. : 167-170

Informa Healthcare

Access to resources Recommend Favorite

Contemporary intracavernous pharmacotherapy for erectile dysfunction in the aging male

By Bella1 Anthony J Brant1 William O Brock2 Gerald B

Aging Health, Vol. 2, Iss. 4, 2006-08 ,pp. : 559-570

Future Medicine

Access to resources Recommend Favorite

Erectile and sexual dysfunction in the aging diabetic male

By Brant William O Bella Anthony J Lue Tom F

Aging Health, Vol. 2, Iss. 6, 2006-12 ,pp. : 1025-1034

Future Medicine

Access to resources Recommend Favorite

Sildenafil in the treatment of erectile dysfunction

By Fenig David M McCullough Andrew

Aging Health, Vol. 3, Iss. 3, 2007-06 ,pp. : 295-303

Future Medicine

Access to resources Recommend Favorite